ACCESSION: MSBNK-SMB_Measured-HSA033P0182005
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.04.01, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 13
COMMENT: RAW_SPEC {'C2neg_4475': {'bp': 10933.0, 'sum': 16303.0}, 'C3neg_4460': {'bp': 10153.0, 'sum': 14888.0}, 'C10neg_4357': {'bp': 9982.0, 'sum': 14348.0}, 'C7neg_4442': {'bp': 9676.0, 'sum': 14827.0}, 'C11neg_4395': {'bp': 8643.0, 'sum': 12822.0}, 'C6neg_4497': {'bp': 8592.0, 'sum': 13176.0}, 'C12neg_4334': {'bp': 7221.0, 'sum': 10340.0}, 'C16neg_4473': {'bp': 6813.0, 'sum': 9644.0}, 'C8neg_4336': {'bp': 5356.0, 'sum': 8432.0}, 'D178neg_4368': {'bp': 5018.0, 'sum': 8333.0}, 'D171neg_4494': {'bp': 4265.0, 'sum': 6469.0}, 'D203neg_4284': {'bp': 3139.0, 'sum': 5715.0}, 'D143neg_4411': {'bp': 2603.0, 'sum': 4895.0}}
COMMENT: RETENTION_TIME_STDEV 0.018
COMMENT: PRECURSOR_M/Z_RAW 182.069387
COMMENT: PRECURSOR_M/Z_STDEV 0.000607
COMMENT: PRECURSOR_IN_MS1 mz 182.069377; int 2.810; delta(ppm) -1.165235
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE +1; mz 181.068980; int 42.338; cor 0.791
COMMENT: PROPOSED_ISOTOPE_STATE +2; mz 180.066166; int 458.063; cor 0.780
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 15.687; C11H9N3; [M-H]1; delta(ppm) -15.687408
COMMENT: PROPOSED_MF SevenGoldenRules 6.282; C6H9N5O2; [M-H]1; delta(ppm) 6.281518
COMMENT: PROPOSED_MF SevenGoldenRules 13.590; C5H13NO6; [M-H]1; delta(ppm) 13.589927
COMMENT: PROPOSED_MF MS-FINDER 3.943; C6H9N5O2; [M-H]-; delta(ppm) 6.321054
COMMENT: PROPOSED_MF MS-FINDER 3.138; C4H14N3O3P; [M-H]-; delta(ppm) -2.751156
COMMENT: PROPOSED_MF MS-FINDER 2.257; C11H9N3; [M-H]-; delta(ppm) -15.773274
COMMENT: PROPOSED_MF MS-FINDER 1.976; C6H17NOS2; [M-H]-; delta(ppm) 8.893717
COMMENT: PROPOSED_MF MS-FINDER 1.937; C5H13NO6; [M-H]-; delta(ppm) 13.666824
COMMENT: PROPOSED_MF SIRIUS5_Sirius 10.729; C6H9N5O2; [M-H]-; delta(ppm) 6.321054
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H9N5O2; [M-H]-; delta(ppm) 6.321054
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.081; C6H9N5O2; [M-H]-; delta(ppm) 6.321054
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.187; C5H14ClN3O2; [M-H]-; delta(ppm) -116468.474386
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.073; C4H14N3O3P; [M-H]-; delta(ppm) -2.751156
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.073; C3H10FN5O3; [M-H]-; delta(ppm) 0.045092
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.734; C8H11N2O3; [M-H]-; delta(ppm) -1.053442
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.982; C2H12N6O2P; [M-H]-; delta(ppm) 4.623315
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.340; CH11N8OS; [M-H]-; delta(ppm) -4.820115
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.391; C6H16O4P; [M-H]-; delta(ppm) -10.125517
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.996; C6H9N5O2; [M-H]-; delta(ppm) 6.321054
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C5H14ClN3O2; [M-H]-; delta(ppm) -116468.474386
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C4H14N3O3P; [M-H]-; delta(ppm) -2.751156
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.292; CGWDNAFNQOBSCK-UHFFFAOYSA-N; [M-H]-; CN(C=O)C1=C(N)N=C(N)N=C1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.118; RHGLLNXRPLUIDG-UHFFFAOYNA-N; [M-H]-; CN1C2NC(=O)NC(=N)C2NC1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; VWHRYODZTDMVSS-SVGMAFHSNA-N; [M-H]-; N[C@@H](CC1=CC(F)=CC=C1)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; XWHHYOYVRVGJJY-QMMMGPOBSA-N; [M-H]-; N[C@@H](CC1=CC=C(F)C=C1)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; NYCRCTMDYITATC-UHFFFAOYSA-N; [M-H]-; C1=CC=C(C(=C1)CC(C(=O)O)N)F
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.286; CGWDNAFNQOBSCK-UHFFFAOYSA-N; [M-H]-; 2,6-Diamino-4-hydroxy-5-N-methylformamidopyrimidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.413; RHGLLNXRPLUIDG-UHFFFAOYNA-N; [M-H]-; UNPD199598
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.767; FJTNLJLPLJDTRM-UHFFFAOYSA-N; [M-H]-; 2-Amino-a-carboline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.559; SNFQMYKPIRCYTJ-UHFFFAOYSA-N; [M-H]-; 3-(1H-pyrrol-2-yl)-1H-indazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.559; WKHKXHWSSPTGFL-UHFFFAOYSA-N; [M-H]-; {9H-benzo[b]pyrrolizin-9-ylidene}hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WKHKXHWSSPTGFL-UHFFFAOYSA-N; [M-H]-; {9H-benzo[b]pyrrolizin-9-ylidene}hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; CGWDNAFNQOBSCK-UHFFFAOYSA-N; [M-H]-; 2,6-Diamino-4-hydroxy-5-N-methylformamidopyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.992; RHGLLNXRPLUIDG-UHFFFAOYNA-N; [M-H]-; UNPD199598
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.881; FJTNLJLPLJDTRM-UHFFFAOYSA-N; [M-H]-; 2-Amino-a-carboline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.816; SNFQMYKPIRCYTJ-UHFFFAOYSA-N; [M-H]-; 3-(1H-pyrrol-2-yl)-1H-indazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.039; CGWDNAFNQOBSCK-UHFFFAOYSA-N; [M-H]-; N-(2,4-diamino-6-oxo-1H-pyrimidin-5-yl)-N-methylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.961; NEVDMPLXCGERDI-UHFFFAOYSA-N; [M-H]-; (4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.825; FJTNLJLPLJDTRM-UHFFFAOYSA-N; [M-H]-; 9H-pyrido[2,3-b]indol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.378; UNDUSVBXIVZGOQ-UHFFFAOYSA-N; [M-H]-; 1H-perimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.665; AGQNTADHDRGUOT-UHFFFAOYSA-N; [M-H]-; 5-amino-1-N-methylimidazole-1,4-dicarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.435; WQJLLOCUCJRMMW-UHFFFAOYSA-N; [M-H]-; 4-amino-2-(dimethylamino)-5-nitroso-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.393; YJQYMUPERFRTJO-UHFFFAOYSA-N; [M-H]-; 3,5-dimethyl-N-nitropyrazole-1-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.220; NCQIPMVIVOABDU-UHFFFAOYSA-N; [M-H]-; N-methyl-5-(methylamino)-3-oxo-2H-1,2,4-triazine-6-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; CBKYBPQWMMTFMT-UHFFFAOYSA-N; [M-H]-; 2-(methylamino)quinoline-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.104; XYEJDFIDVKWWTR-UHFFFAOYSA-N; [M-H]-; 2-amino-4-phenyl-1H-pyrrole-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; LXVVOJYMNGCZEV-UHFFFAOYSA-N; [M-H]-; 9H-pyrrolo[3,2-h]quinolin-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.908; DXXUIIMDJKUSES-UHFFFAOYSA-N; [M-H]-; 2-amino-4-methylquinoline-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; PZUJQFOCMARCSE-UHFFFAOYSA-N; [M-H]-; 3H-benzo[e]benzimidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.891; WUHVINYLKIDGKO-UHFFFAOYSA-N; [M-H]-; 4-(3-methylpyrazol-1-yl)benzonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.886; FAMJRKMLLLJOGZ-UHFFFAOYSA-N; [M-H]-; 4-(2-methylimidazol-1-yl)benzonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.553; LYSASALARDKFIC-UHFFFAOYSA-N; [M-H]-; 1-(1-methyltetrazol-5-yl)azetidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.523; STGZUKHALNSQAG-UHFFFAOYSA-N; [M-H]-; phenyl(pyridin-4-yl)diazene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.454; LUSFCTSUDCCYLQ-UHFFFAOYSA-N; [M-H]-; 4-(imidazol-1-ylmethyl)benzonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.273; FPZADNOIMZEBTC-UHFFFAOYSA-N; [M-H]-; 4-(pyrazol-1-ylmethyl)benzonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.208; NLYRPESMFJTOLW-UHFFFAOYSA-N; [M-H]-; 6-phenyl-5H-imidazo[1,2-b]pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.207; BTCQQQUDIZILEJ-UHFFFAOYSA-N; [M-H]-; 3-(imidazol-1-ylmethyl)benzonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.191; IJNRBGYVKVGQMR-UHFFFAOYSA-N; [M-H]-; 2-(1-phenylpyrazol-3-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.184; SQKQWKKZZCFSAW-UHFFFAOYSA-N; [M-H]-; 10H-imidazo[2,1-c][1,4]benzodiazepine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; BWPUFKQLCCDCHQ-UHFFFAOYSA-N; [M-H]-; 2-(1-phenylpyrazol-4-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; AOZFOGBVCGZTHH-UHFFFAOYSA-N; [M-H]-; 2-(4-imidazol-1-ylphenyl)acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -131.792; NCQIPMVIVOABDU; [M-H]-; N-methyl-5-(methylamino)-3-oxo-2H-1,2,4-triazine-6-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.949; WQJLLOCUCJRMMW; [M-H]-; 6-Amino-2-dimethylamino-5-nitroso-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.594; CGWDNAFNQOBSCK; [M-H]-; Mftahp
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.538; RZZHQBHPEGCVIV; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.022; YTHHWTLOZQBLLX; [M-H]-; 1-Methyl-N(4)-ureidocytosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.879; YJQYMUPERFRTJO; [M-H]-; 1-Nitroguanyl-3,5-dimethylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.131; NCQIPMVIVOABDU; [M-H]-; N-methyl-5-(methylamino)-3-oxo-2H-1,2,4-triazine-6-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -131.401; CGWDNAFNQOBSCK; [M-H]-; N-(2,4-diamino-6-hydroxypyrimidin-5-yl)-N-methylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -131.567; NCQIPMVIVOABDU; [M-H]-; as-Triazine-6-carboxamide, 3-hydroxy-N-methyl-5-(methylamino)-, hydrate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -150.705; RZZHQBHPEGCVIV; [M-H]-; 1-(1-Methyl-5-hydroxy-1,6-dihydro-1,2,4-triazine-6-ylidene)-3-methylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -153.484; WQJLLOCUCJRMMW; [M-H]-; 6-Amino-2-(dimethylamino)-5-nitroso-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -162.430; AGQNTADHDRGUOT; [M-H]-; 5-Amino-1-(n-methylcarbamoyl)imidazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.142; NEVDMPLXCGERDI; [M-H]-; N-(4-Methoxy-6-methyl-1,3,5-triazin-2-yl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -202.195; YTHHWTLOZQBLLX; [M-H]-; 1-Methyl-N(4)-ureidocytosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -220.116; YJQYMUPERFRTJO; [M-H]-; 3,5-dimethyl-N'-nitropyrazole-1-carboximidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -310.891; LYSASALARDKFIC; [M-H]-; 1-(1-Methyltetrazol-5-yl)azetidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.018; CGWDNAFNQOBSCK; [M-H]-; N-(2,4-diamino-6-hydroxypyrimidin-5-yl)-N-methylformamide
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H8N5O2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 Âµm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 4.881
MS$FOCUSED_ION: PRECURSOR_M/Z 182.069499
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-014i-9100000000-7a017cc3cad27270388c
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0084720 999.0000 69.008433 6.8108 276.74 0.7397 13 f{C2H1N2O1}/-13.97ppm,p-C4H7N3O1
  96.0185033 304.2971 96.018455 9.8939 86.27 0.7052 11 f{C5H4O2}/-33.06ppm,p-C1H4N5
  112.0138425 191.9091 112.013799 7.7848 70.71 1.0000 11 f{C3H2N3O2}/-12.56ppm,p-C3H6N2
PK$NUM_PEAK: 3
PK$PEAK: m/z int. rel.int.
  69.008472 999.00 999
  96.018503 304.30 304
  112.013842 191.91 191
//
